
Naurex
VerifiedDeveloping novel modulators of the NMDA receptor to treat challenging diseases of the brain and central nervous system
Launch date
Employees
Ownership
Firm valuation
$560m (Dealroom.co estimates Jul 2015.)
Evanston Illinois (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$1.1m | Debt | ||
$18m | Series A | ||
$38m | Series B | ||
$25m | Series C | ||
$80m | Series C | ||
$560m Valuation: $560m | Acquisition | ||
Total Funding | $161m |